These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20880313)

  • 1. Oral megadose methylphenidate ingestion for suicide attempt.
    Poulton A
    Pediatr Int; 2010 Oct; 52(5):852. PubMed ID: 20880313
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral megadose methylphenidate ingestion for suicide attempt.
    Fettahoglu EC; Satilmis A; Gokcen C; Ozatalay E
    Pediatr Int; 2009 Dec; 51(6):844-5. PubMed ID: 20158630
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of suicide attempt with long-acting methylphenidate (Concerta).
    Ozdemir E; Karaman MG; Yurteri N; Erdogan A
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):103-5. PubMed ID: 21432595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADHD and psychostimulants - overdiagnosis and overprescription.
    Dunlop AJ; Newman LK
    Med J Aust; 2016 Mar; 204(4):139. PubMed ID: 26937659
    [No Abstract]   [Full Text] [Related]  

  • 5. Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder.
    Coetzee M; Kaminer Y; Morales A
    Subst Abus; 2002 Sep; 23(3):165-9. PubMed ID: 12444349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate misuse in adult patients and the impact of therapeutic use.
    Jensen LS; Pagsberg AK; Dalhoff K
    Hum Exp Toxicol; 2015 May; 34(5):460-7. PubMed ID: 25062974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fatality due to the intranasal abuse of methylphenidate (Ritalin).
    Massello W; Carpenter DA
    J Forensic Sci; 1999 Jan; 44(1):220-1. PubMed ID: 9987890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical inquiries. Does increasing methylphenidate dose aid symptom control in ADHD?
    Ibay AD; Bascelli LM; Graves RS; Hill J
    J Fam Pract; 2003 May; 52(5):400, 403. PubMed ID: 12737774
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive Improvement of Attention and Inhibition in the Late Afternoon in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Osmotic-Release Oral System Methylphenidate.
    Slama H; Fery P; Verheulpen D; Vanzeveren N; Van Bogaert P
    J Child Neurol; 2015 Jul; 30(8):1000-9. PubMed ID: 25296928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
    Yoo HK; Park S; Wang HR; Lee JS; Kim K; Paik KW; Yum MS; Ko TS
    Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after accidental pediatric ingestions of (dextro)amphetamine and methylphenidate.
    LoVecchio F; Ozimek J; Sawyers B; Thole D
    Am J Emerg Med; 2009 Oct; 27(8):933-4. PubMed ID: 19857410
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylphenidate and chromosome damage.
    Jacobson-Kram D; Mattison D; Shelby M; Slikker W; Tice R; Witt K
    Cancer Lett; 2008 Feb; 260(1-2):216-8. PubMed ID: 18055105
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder.
    Alloway TP
    Dev Med Child Neurol; 2011 Sep; 53(9):780. PubMed ID: 21518347
    [No Abstract]   [Full Text] [Related]  

  • 16. Need for bedtime dose of ritalin.
    Rogers WB
    Pediatrics; 1996 Aug; 98(2 Pt 1):314. PubMed ID: 8692642
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between symptomatic and functional changes of Korean children and adolescents with attention-deficit/hyperactivity disorder treated with osmotic-controlled release oral delivery system-methylphenidate.
    Kim E; Cheon KA; Joung YS; Kim JY; Song DH
    Clin Neuropharmacol; 2015; 38(1):30-5. PubMed ID: 25580917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 20. [Attention deficit hyperactivity disorder in children].
    Bervoets L
    J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.